Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice
The Oncologist · 04.06.2025 · 30 (6)
DOI: 10.1093/oncolo/oyaf142 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 10.06.2025. Verfasst von Alessandro Broccoli und 14 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy. Hauptthemen laut MEDLINE: Spleen, Splenic Neoplasms, Hematologic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Solid splenic lesions may be the expression of a lymphoproliferative disease spreading to the spleen or appear as the only manifestation of possible neoplastic diseases, mainly hematologic malignancies. Therefore, biopsy is of uttermost importance in clarifying their nature. Patients and Methods Forty-four patients with splenic nodular lesions suspected of hematologic disease underwent spleen contrast-enhanced ultrasonography and contextual biopsy using an 18-gauge needle. All procedures were performed on an outpatient basis. Patients with inconclusive findings or with a diagnosis of unaffected splenic tissue were followed up to discriminate between true and false-negative results.
Results
All procedures ended up with sampling of splenic tissue without severe complications requiring hospitalization or supportive countermeasures. None was interrupted because of adverse event (AE)s. Out of 44 samples, a final diagnosis was accomplished in 39 cases, with a diagnostic yield of 88.6%. A diagnosis of lymphoma was made in 22 cases. Other diagnoses included: splenic metastases and splenic sarcoma (3 cases each), non-neoplastic lesions (3 cases), and unaffected splenic tissue (8 cases). Among the latter 8 patients, 1 received a diagnosis of Hodgkin lymphoma by marrow biopsy. All the other 7 patients never received a diagnosis of neoplasm and were true negative. Among the 5 patients with insufficient sampling, 3 were never diagnosed with a neoplasm during follow-up; 1 had myelofibrosis and 1 angiosarcoma. The sensitivity of the procedure was 96.6%; specificity was 100% and accuracy was 86.4%.
Conclusions
Ultrasound-guided core needle biopsy of splenic nodular lesions can be safely performed on an outpatient basis with no severe AEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy.
- Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
- Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Alessandro Broccoli
Zitieren
APA
Broccoli, A., Bakken, S. M., Argnani, L., Mazzoni, C., Di Benedetto, D., Machado, M., Masi, L., Venturoli, N., Agostinelli, D., Casadei, B., Gugliotta, G., Pellegrini, C., Stefoni, V., Serra, C., & Zinzani, P. L. (2025). Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice. The Oncologist, 30(6). https://doi.org/10.1093/oncolo/oyaf142
Vancouver
Broccoli A, Bakken SM, Argnani L, Mazzoni C, Di Benedetto D, Machado M, et al. Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice. The Oncologist. 2025;30(6). doi:10.1093/oncolo/oyaf142
BibTeX
@article{Broccoli2025,
author = {Broccoli, Alessandro and Bakken, Sofia Maria and Argnani, Lisa and Mazzoni, Camilla and Di Benedetto, Davide and Machado, Marta and Masi, Livia and Venturoli, Nicola and Agostinelli, Daniela and Casadei, Beatrice and Gugliotta, Gabriele and Pellegrini, Cinzia and Stefoni, Vittorio and Serra, Carla and Zinzani, Pier Luigi},
title = {Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practice},
journal = {The Oncologist},
year = {2025},
volume = {30},
number = {6},
doi = {10.1093/oncolo/oyaf142}
}
EUVIMED